A new Rutgers University study published in the journal Health Affairs shows use of a long-acting injectable form of opioid ...
There was a substantial increase in recent years in the use of a form of the primary medication to treat opioid use disorder, ...
Long-acting injectable adoption remains low, but Indivior's market position, payer access and consumer campaign could help ...
The Salt Lake Harm Reduction Project (SHRP) has created Naloxey-Boxeys to increase access to naloxone, a prescription medication used to reverse opioid overdoses, and potentially save lives.
NEW YORK, Nov. 30 (UPI) --New vending machines have been cropping up around the country as innovative public health tools to combat overdose deaths from fentanyl -- a potent synthetic opioid, or ...
Figure illustrates the proportion of Medicaid managed care plans (MCP) in state covering at least one generic injectable or generic or brand intranasal naloxone formulation without any restrictions.
Exclusive: Fears that US companies may withdraw more medicines as global markets react to policy changes by the Trump administration ...
Naloxone is a fast-acting drug used to reverse opioid overdoses. Naltrexone helps reduce cravings and blocks the high from opioids or alcohol. Naloxone can be obtained without a prescription at many ...
Production issues with Pfizer’s injectable version of naloxone, a lifesaving overdose reversal drug, has caused a shortage of the drug, affecting healthcare providers across the country, The Boston ...
The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency announced ...
Teva Pharmaceuticals USA snagged US Food and Drug Administration (FDA) final approval for the first generic naloxone hydrochloride nasal spray known as Narcan, the agency announced on Friday. The life ...
There has been a substantial increase in recent years in the use of a form of primary medication to treat opioid use disorder ...